EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity

Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe

Clinical and Molecular Hepatology · 2023

DOI: 10.3350/cmh.2023.0035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2023. Verfasst von Hong-Kyu Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Subdivision of Endocrinology and Metabolism, Health Screening and Promotion Center, Asan Medical Center, Seoul, Korea. Hauptthemen laut MEDLINE: Sarcopenia, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: To investigate whether non-alcoholic fatty liver disease (NAFLD) in individuals without generalized obesity is associated with visceral fat obesity (VFO), sarcopenia, and/or myosteatosis.

Methods

This cross-sectional analysis included 14,400 individuals (7,470 men) who underwent abdominal computed tomography scans during routine health examinations. The total abdominal muscle area (TAMA) and skeletal muscle area (SMA) at the 3rd lumbar vertebral level were measured. The SMA was divided into the normal attenuation muscle area (NAMA) and low attenuation muscle area, and the NAMA/TAMA index was calculated. VFO was defined by visceral to subcutaneous fat ratio, sarcopenia by body mass index-adjusted SMA, and myosteatosis by the NAMA/TAMA index. NAFLD was diagnosed with ultrasonography.

Results

Of the 14,400 individuals, 4,748 (33.0%) had NAFLD, and the prevalence of NAFLD among non-obese individuals was 21.4%. In regression analysis, both sarcopenia (men: odds ratio [OR] 1.41, 95% confidence interval [CI] 1.19–1.67, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaNon-alcoholic Fatty Liver DiseaseMaleHumansFemaleCross-Sectional StudiesIntra-Abdominal FatObesityMuscle, Skeletal

Stichwörter der Autor:innen

Abdominal obesityMyosteatosisNon-alcoholic fatty liver diseaseSarcopenia

Autor:innen und Institutionen

  • Subdivision of Endocrinology and Metabolism, Health Screening and Promotion Center, Asan Medical Center, Seoul, Korea.
  • Subdivision of Gastroenterology and Hepatology, Health Screening and Promotion Center, Asan Medical Center, Seoul, Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Asan Diabetes Center, Asan Medical Center, Seoul, Korea.

Zitieren

APA

Kim, H. K., Bae, S. J., Lee, M. J., Kim, E. H., Park, H., Kim, H. S., Cho, Y. K., Jung, C. H., Lee, W. J., & Choe, J. (2023). Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2023.0035

Vancouver

Kim HK, Bae SJ, Lee MJ, Kim EH, Park H, Kim HS, et al. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity. Clinical and Molecular Hepatology. 2023. doi:10.3350/cmh.2023.0035

BibTeX
@article{Kim2023,
  author = {Kim, Hong-Kyu and Bae, Sung-Jin and Lee, Min Jung and Kim, Eun Hee and Park, Hana and Kim, Hwi Seung and Cho, Yun Kyung and Jung, Chang Hee and Lee, Woo Je and Choe, Jaewon},
  title = {Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity},
  journal = {Clinical and Molecular Hepatology},
  year = {2023},
  doi = {10.3350/cmh.2023.0035}
}
Kostenlos starten →